framycetin has been researched along with peoniflorin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bai, X; Fan, Z; Han, Y; Li, H; Li, J; Sun, G; Wang, H; Wang, M; Xu, L; Yang, Q; Yu, X; Zhang, D; Zhang, L; Zhou, M | 1 |
1 other study(ies) available for framycetin and peoniflorin
Article | Year |
---|---|
Paeoniflorin reduces neomycin-induced ototoxicity in hair cells by suppression of reactive oxygen species generation and extracellularly regulated kinase signalization.
Topics: Animals; Antioxidants; Apoptosis; Cells, Cultured; Evoked Potentials, Auditory, Brain Stem; Extracellular Signal-Regulated MAP Kinases; Glucosides; Hair Cells, Auditory; Hearing Loss; Mice, Inbred C57BL; Mitochondria; Monoterpenes; Neomycin; Reactive Oxygen Species; Signal Transduction | 2018 |